Transvaginal ultrasound cervical length screening
OtherSerial transvaginal ultrasound cervical length scan every week from 16 to 24 weeks
NCT Number: NCT02923973
Preterm birth (PTB) is the major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB.Different strategies have been adopted for prevention of PTB. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of singleton gestations with both prior spontaneous PTB and TVU CL ≤25mm, and not in singletons without prior PTB, nor in multiple gestations.
However, so far there are no level-1 data on the efficacy of TVU CL screening neither in low risk nor in high risk pregnancy Thus, the investigators aim to assess the efficacy of a policy of TVU CL screening in singleton pregnancy with prior spontaneous PTB
Interested in participating?
Request Info18 year–50 year
Female
Interventional
Not applicable
Gabriele Saccone, Naples, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Serial transvaginal ultrasound cervical length scan every week from 16 to 24 weeks
Time frame: Less than 37 weeks gestation
Time frame: Time of delivery
Time frame: Less than 24, 28, 34 weeks gestation
Time frame: Time of delivery
Time frame: Time of delivery
Birth weight <2500g
Time frame: Between birth and 28 days of age
Time frame: Between birth and 28 days of age
Includes necrotizing enterocolitis, intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia (BPD), retinopathy, blood-culture proven sepsis and neonatal death
Time frame: Between birth and 28 days of age
Federico II University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05703425
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
New Brunswick, New Jersey, United States
View Trial DetailsNCT07458802
Antenatal Care, Antenatal Health
Gaborone, Botswana
View Trial DetailsNCT07402668
Artificial Intelligence (AI) in Diagnosis, Female Urogenital Diseases and Pregnancy Complications
Aabenraa, Denmark
View Trial DetailsNCT05787509
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Guangzhou, China
View Trial Details